Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Tumor Necrosis Factor-alpha MeSH Descriptor Data 2026


MeSH Heading
Tumor Necrosis Factor-alpha
Tree Number(s)
D09.400.430.965
D12.644.276.374.500.800
D12.644.276.374.750.626
D12.776.124.900
D12.776.395.930
D12.776.467.374.500.800
D12.776.467.374.750.626
D23.529.374.500.800
D23.529.374.750.626
Unique ID
D014409
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D014409
Scope Note
Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.
Entry Term(s)
Cachectin
Cachectin-Tumor Necrosis Factor
TNF Superfamily, Member 2
TNF-alpha
TNFalpha
Tumor Necrosis Factor
Tumor Necrosis Factor Ligand Superfamily Member 2
Registry Numbers
0
Previous Indexing
Endotoxins (1975-1987)
Glycoproteins (1975-1987)
Necrosis (1975-1987)
See Also
Adalimumab
Certolizumab Pegol
Infliximab
Public MeSH Note
2005; see TUMOR NECROSIS FACTOR 1988-2005
History Note
2005(1988)
Date Introduced
1988/01/01
Last Updated
2023/03/16
Tumor Necrosis Factor-alpha Preferred
page delivered in 0.161s